Edmond de Rothschild Investment Partners Co-Leads Complix Series B
Edmond de Rothschild Investment Partners has co-led the Series B financing round of Complix with GIMV. Complix, formed in 2008, was founded in Hasselt, Belgium. The funds will be invested in developing a first set of therapeutic Alphabodies(TM) to treat cancer and autoimmune indications and to further develop and validate the company's unique Alphabody platform.
26 June 2013•4 mins read
